SQSTM1 and cancer: Notably, these compounds may be particularly beneficial for cancers such as READ, COAD, LIHC, PRAD, BRCA, ESCA, THYM, LUAD, and LUSC, in which p62 expression is strongly associated with immune-cell exclusion and checkpoint upregulation.